How big is the Horseradish Peroxidase Market?
According to 6Wresearch internal database and industry insights, the
Global Horseradish Peroxidase Market was valued at USD 0.34 Billion in 2024 and is projected to reach USD 0.5 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.70% during the forecast period (2025–2031).
The market is witnessing rising demand due to increased use in diagnostics, ELISA kits, biotechnology, and molecular biology research.
Key Growth Drivers of the Horseradish Peroxidase Market
- Increased usage in ELISA and immunoassays
- Growth in biotechnology and diagnostics research
- Rising demand for biosensors and labeling techniques
- Advancements in precision diagnostics
- Expansion of R&D across pharma and academic sectors
Horseradish Peroxidase Market Trends
The horseradish peroxidase market is experiencing rapid adoption of recombinant horseradish peroxidase (rHRP) for high-sensitivity diagnostic kits and laboratory testing. There is growing integration of HRP in nanoparticle-based detection systems and microfluidic platforms. Labs are shifting to custom HRP conjugates to improve assay precision and detection efficiency. Additionally, HRP-based biosensors are becoming more prevalent for real-time disease monitoring and environmental applications.
Emerging Developments in the Horseradish Peroxidase Market
The most recent technology is aimed at producing horseradish peroxidase recombinantly (more stable, high yield, and enzyme capacity). New HRP variants adapted toward next-gen diagnostics and uses in industry are being made possible through enzyme engineering. Research organizations and startups are trying HRP nanoparticle hybrids with high-throughput testing platforms. Moreover, the academic organizations in partnership with biotech organizations are facilitating faster invention of sustainable expression systems to maintain large-scale production.
Major Companies in the Horseradish Peroxidase Market
- Merck KGaA (Sigma-Aldrich)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories
- BBI Solutions
- TOYOBO Co., Ltd.
- Abcam plc
- Promega Corporation
- Enzo Life Sciences, Inc.
- GenScript Biotech Corporation
- Agilent Technologies
How big is the Horseradish Peroxidase Market : FAQ's
The horseradish peroxidase market was valued at USD 0.34 million in 2024 and is projected to reach USD 0.5 million by 2031.
It is expected to grow at a CAGR of 5.70% during 2025–2031.
Pharmaceuticals, diagnostics (ELISA), biotechnology, and academic research.
Recombinant HRP production, nanoparticle integration, biosensors, and microfluidic platforms.
Rise in immunoassays, demand for precision diagnostics, and growth in biotech R&D.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com